Colimo
ActiveSummary
Colimo has been active since 1984 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €119,749 and a net result of -€2,406. Equity remains stable across the filed fiscal years (±0.3% per year). Its solvency ranks better than 69% of 5669 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
02-08
NBB filing
Annual accounts filed
fiscal year 2025 · full schema · 2 days late
02-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 2 days late
2025
31-12
Financial
Liquidity times 64current ratio 166.96
Current ratio from 2.61 to 166.96; short-term debt falls from €36,189 to €275.
2024
12-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 12 days late
2023
31-12
Financial
Weakest financial yearnet -€5,721
Net result drops to -€5,721, the lowest in the series; recovery starts the following year.
22-06
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Highest result since 2018net €6,193 ▲352%
Operating result €5,206, net result €6,193, both a record.
12-06
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
19-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial
Back to profitnet €3,604
Net result €3,604 after 2 loss-making years.
29-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
23-08
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 23 days late
2018
20-08
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 20 days late
2015
13-06
NBB filing
Annual accounts filed
fiscal year 2014 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.